Redefining the value in partnerships ahead of DCAT Week

As the industry emerges from a prolonged funding slowdown, the roundtable highlights cautious optimism. Rather than a broad-based recovery, participants describe a selective, research-driven uptick focused on clinic-ready assets and higher-complexity modalities. Discussions have shifted from speculative experimentation to practical considerations, including manufacturability, timeline efficiency and the ability to scale reliably. This suggests growth that is deliberate, technology selective and weighted toward assets with clearer commercial pathways.

LATEST VIDEO

Latest news

8th May 2026

Lonza Delivers Strong Performance in Q1 2026 in Line with Expectations and Confirms Full-Year Outlook 2026

7th May 2026

Bristol Myers Squibb Licenses Antibody-Drug Conjugate Technology from Lonza

6th May 2026

Neuland secures development collaboration with LIR Life Sciences for transdermal GLP-1

6th May 2026

FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media

6th May 2026

Symeres appoints Henning Steinhagen as CEO to drive next phase of strategic growth

5th May 2026

Hongene Demonstrates Advanced Oligonucleotide CDMO Capabilities Through Support of SiranBio’s Dual-Target siRNA Program

5th May 2026

Syngene strengthens leadership team with two key appointments to support next phase of growth

5th May 2026

AddParts bolsters pharmaceutical manufacturing resilience with funding to support virtual storeroom innovations

5th May 2026

Alcami Completes Acquisition of Tjoapack

4th May 2026

HAS Healthcare Advanced Synthesis Group Announces Strategic Investments in Biodelphis Therapeutics

4th May 2026

Ardena Strengthens Executive Team to Drive its Next Phase of Growth

This week’s featured articles

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Axplora: Mastering complexity

Partnered with top industry events and organisations